IMBiologics아이엠바이오로직스
493280 · KOSDAQ · ₩493280 · 아이엠바이오로직스
₩13,800▼ ₩430 (3.02%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | |
|---|---|---|
| Gross margin | 2.6% | 2.6% |
| Operating margin | 2.6% | 2.6% |
| Net margin | 7.5% | 7.5% |
Growth (year on year)
| TTM | 2025 | |
|---|---|---|
| Revenue growth | 0.0% | — |
| Operating income growth | 0.0% | — |
| Net income growth | 0.0% | — |
Returns
| TTM | 2025 | |
|---|---|---|
| Return on equity | 0.9% | 1.2% |
| Return on assets | 0.9% | 1.2% |
Leverage and liquidity
| TTM | 2025 | |
|---|---|---|
| Liabilities to equity | 2.0% | 2.5% |
| Net debt to equity | −97.3% | −97.6% |
| Current ratio | 9,741.0% | 7,301.4% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: IMBiologics / 아이엠바이오로직스 / 493280 / KRX:493280
Source: KRX statistical information